Omnicell, Inc. (NASDAQ:OMCL – Get Free Report)’s share price dropped 5.6% during trading on Thursday . The company traded as low as $27.18 and last traded at $27.40. Approximately 165,959 shares changed hands during mid-day trading, a decline of 67% from the average daily volume of 505,545 shares. The stock had previously closed at $29.03. […]
Frazier Life Sciences Management L.P. lifted its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 44.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 885,165 shares of the company’s stock after acquiring an additional 271,122 shares during the […]
Forest Avenue Capital Management LP acquired a new stake in shares of Cleveland-Cliffs Inc. (NYSE:CLF – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 303,900 shares of the mining company’s stock, valued at approximately $6,206,000. Cleveland-Cliffs comprises 2.1% […]
Forest Avenue Capital Management LP bought a new stake in Cleveland-Cliffs Inc. (NYSE:CLF – Free Report) during the 4th quarter, HoldingsChannel reports. The firm bought 303,900 shares of the mining company’s stock, valued at approximately $6,206,000. Cleveland-Cliffs makes up 2.1% of Forest Avenue Capital Management LP’s investment portfolio, making the stock its 18th largest position. […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Free Report) Director Floyd F. Petersen sold 3,000 shares of Amphastar Pharmaceuticals stock in a transaction dated Monday, June 10th. The stock was sold at an average price of $41.40, for a total value of $124,200.00. Following the completion of the sale, the director now directly owns 78,409 shares […]